Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Effect of the Metabotropic Glutamate Receptor Type 5 Negative Allosteric Modulator Dipraglurant on Motor and Non-Motor Symptoms of Parkinson's Disease.
Cells. 2023 Mar 24;12(7):1004. doi: 10.3390/cells12071004.
Cells. 2023.
PMID: 37048075
Free PMC article.
A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson's disease.
Le Poul E, Boléa C, Girard F, Poli S, Charvin D, Campo B, Bortoli J, Bessif A, Luo B, Koser AJ, Hodge LM, Smith KM, DiLella AG, Liverton N, Hess F, Browne SE, Reynolds IJ.
Le Poul E, et al. Among authors: bessif a.
J Pharmacol Exp Ther. 2012 Oct;343(1):167-77. doi: 10.1124/jpet.112.196063. Epub 2012 Jul 11.
J Pharmacol Exp Ther. 2012.
PMID: 22787118
Item in Clipboard
Characterization of an mGluR2/3 negative allosteric modulator in rodent models of depression.
Campo B, Kalinichev M, Lambeng N, El Yacoubi M, Royer-Urios I, Schneider M, Legrand C, Parron D, Girard F, Bessif A, Poli S, Vaugeois JM, Le Poul E, Celanire S.
Campo B, et al. Among authors: bessif a.
J Neurogenet. 2011 Dec;25(4):152-66. doi: 10.3109/01677063.2011.627485.
J Neurogenet. 2011.
PMID: 22091727
Item in Clipboard
Cite
Cite